Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Molecular and Cellular Biology
K M LonerganW G Kaelin

Abstract

The von Hippel-Lindau tumor suppressor protein (pVHL) binds to elongins B and C and posttranscriptionally regulates the accumulation of hypoxia-inducible mRNAs under normoxic (21% O2) conditions. Here we report that pVHL binds, via elongin C, to the human homolog of the Caenorhabditis elegans Cul2 protein. Coimmunoprecipitation and chromatographic copurification data suggest that pVHL-Cul2 complexes exist in native cells. pVHL mutants that were unable to bind to complexes containing elongin C and Cul2 were likewise unable to inhibit the accumulation of hypoxia-inducible mRNAs. A model for the regulation of hypoxia-inducible mRNAs by pVHL is presented based on the apparent similarity of elongin C and Cul2 to Skp1 and Cdc53, respectively. These latter proteins form complexes that target specific proteins for ubiquitin-dependent proteolysis.

References

Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·I A WilsonS Brenner
Sep 1, 1981·Journal of Virology·E HarlowN M Williamson
Aug 1, 1995·Nature Medicine·O IliopoulosW G Kaelin
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·K P GarrettJ W Conaway
Jul 30, 1993·Biochemical and Biophysical Research Communications·K MoriiR Kuwano
Jul 1, 1994·The Tohoku Journal of Experimental Medicine·K SatoT Kato
May 1, 1994·Nature Genetics·J R GnarraF M Duh
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·S LeeR D Klausner
Jan 1, 1996·Methods in Enzymology·R C ConawayJ W Conaway
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·J R GnarraW M Linehan
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·O IliopoulosM A Goldberg
Oct 1, 1996·Current Biology : CB·P K Jackson
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A PauseR D Klausner
May 30, 1997·The Journal of Biological Chemistry·T KamitaniE T Yeh

❮ Previous
Next ❯

Citations

Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·K IwaiA Pause
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Jul 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·A R SchoenfeldR D Burk
May 10, 2001·International Journal of Hematology·B T KileW S Alexander
Sep 14, 2002·The Journal of Biological Chemistry·Liangyou RuiMorris F White
Aug 15, 2003·American Journal of Physiology. Cell Physiology·C Van DortM Burnatowska-Hledin
Sep 16, 2004·Molecular and Cellular Biology·Ranjit S BindraPeter M Glazer
Mar 14, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kun LuoXiao-Fang Yu
Mar 9, 2007·The Journal of Biological Chemistry·Jian FuMark B Taubman
Oct 2, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Michelle L GervaisMichael Ohh
May 15, 2008·Expert Opinion on Biological Therapy·Elizabeth Cartwright Pfaffenroth, W Marston Linehan
Jul 9, 2008·Acta Oncologica·Zhang CaoWon Sang Park
Mar 3, 2009·Nature Medicine·Yi WangMichael Ohh
Mar 4, 2010·The Journal of Clinical Investigation·Michele M HickeyM Celeste Simon
Mar 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·Yi WangMichael Ohh
Jun 12, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Chih-Hung LinTien Hsu
Dec 24, 2014·Nature Reviews. Cancer·Lucy GossageEamonn R Maher
Feb 18, 2016·Molecular and Cellular Biochemistry·Yuka YamakiHiroyuki Kawahara
Oct 27, 2016·The Journal of Biological Chemistry·Shu-Ching HuangEdward J Benz
Sep 15, 2018·Scientific Reports·Eliezer KeinanYaakov Nahmias
Nov 26, 2019·The Journal of Clinical Investigation·Javid Moslehi, W Kimryn Rathmell
Nov 7, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Shilatifard
Aug 24, 1999·Current Opinion in Nephrology and Hypertension·H T Cohen
Dec 28, 1999·Annual Review of Cell and Developmental Biology·R J Deshaies

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.